Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowl...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-08-01
|
Series: | Clinical Ophthalmology |
Online Access: | https://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH |
id |
doaj-e688b2d24370457380265d79bd4cf4cb |
---|---|
record_format |
Article |
spelling |
doaj-e688b2d24370457380265d79bd4cf4cb2020-11-24T22:59:40ZengDove Medical PressClinical Ophthalmology1177-54832017-08-01Volume 111567156834443Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]Korol ARZborovska OKustryn TDorokhova OPasyechnikova NKorol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original articlehttps://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N |
spellingShingle |
Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] Clinical Ophthalmology |
author_facet |
Korol AR Zborovska O Kustryn T Dorokhova O Pasyechnikova N |
author_sort |
Korol AR |
title |
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] |
title_short |
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] |
title_full |
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] |
title_fullStr |
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] |
title_full_unstemmed |
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum] |
title_sort |
intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [corrigendum] |
publisher |
Dove Medical Press |
series |
Clinical Ophthalmology |
issn |
1177-5483 |
publishDate |
2017-08-01 |
description |
Korol AR, Zborovska O, Kustryn T, et al. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clin Ophthalmol. 2017;11:1315–1320.The Acknowledgement implies that Bayer Pharmaceuticals sponsored the study, this is not correct. The acknowledgment should state: The authors take full responsibility for the scope, direction, and content of the manuscript, and have approved the submitted manuscript. Medical writing support was provided by Corey Eagan, MPH, of PAREXEL, and was funded by Bayer Pharmaceuticals. Read the original article |
url |
https://www.dovepress.com/corrigendum-intravitreal-aflibercept-for-choroidal-neovasculariza-peer-reviewed-article-OPTH |
work_keys_str_mv |
AT korolar intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT zborovskao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT kustrynt intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT dorokhovao intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum AT pasyechnikovan intravitrealafliberceptforchoroidalneovascularizationassociatedwithchorioretinitisapilotstudycorrigendum |
_version_ |
1725644260730994688 |